Turnstone Biologics Corp. Amends 8-K Filing
| Field | Detail |
|---|---|
| Company | Turnstone Biologics Corp. |
| Form Type | 8-K/A |
| Filed Date | Jul 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, corporate-governance, financial-statements
TL;DR
Turnstone Biologics filed an amendment to its 8-K, updating director/officer info and financials.
AI Summary
Turnstone Biologics Corp. filed an amendment (8-K/A) on July 17, 2025, to its report originally dated June 26, 2025. The amendment pertains to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes financial statements and exhibits.
Why It Matters
This amendment provides updated information regarding changes in the company's board and executive team, as well as financial disclosures, which are crucial for investors to understand the company's governance and financial health.
Risk Assessment
Risk Level: low — This filing is an amendment to a previous report and primarily concerns corporate governance and financial statement updates, not a material event like a merger or bankruptcy.
Key Players & Entities
- Turnstone Biologics Corp. (company) — Registrant
- June 26, 2025 (date) — Date of earliest event reported
- July 17, 2025 (date) — Filing date of amendment
- Delaware (jurisdiction) — State of incorporation
- 9310 Athena Circle, Suite 300 (address) — Principal executive offices
- La Jolla, California (location) — City and State of principal executive offices
FAQ
What specific items are being amended in this 8-K/A filing?
This 8-K/A amends items related to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, in addition to financial statements and exhibits.
What is the original report date being amended?
The original report date being amended is June 26, 2025.
When was this amendment filed with the SEC?
This amendment (8-K/A) was filed on July 17, 2025.
What is the principal business address of Turnstone Biologics Corp.?
The principal business address is 9310 Athena Circle, Suite 300, La Jolla, California 92037.
What is the SIC code for Turnstone Biologics Corp.?
The Standard Industrial Classification (SIC) code is 2836, for Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on July 17, 2025 regarding Turnstone Biologics Corp..